Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

The Future of Biomedical Research

The Future of Biomedical Research VIEWPOINT ONLINE FIRST Second, for decades there have been strong Congressio- Ezekiel J. Emanuel, MD, PhD nal champions of the NIH. But such champions are quickly becoming an endangered species in Washington. John Por- HE COMMUNITY OF BIOMEDICAL RESEARCHERS IS ANX- ter, the former Illinois Republican Congressman who helped ious, if not downright depressed, about the future, guide the legislation that doubled the NIH budget, retired and there is good reason for this pessimism. For de- from politics in 2001; Senator Arlen Specter, who almost Tcades the importance of biomedical research was a single-handedly insisted on including a one-time $10 bil- reliable pillar of bipartisan agreement, as evidenced by the lion appropriation for the NIH in the American Recovery continuous high levels of funding that both parties have sus- and Reinvestment Act, recently died, as did the indefati- tained during the last 3 presidential administrations. From gable defender of NIH funding, Senator Ted Kennedy. No the beginning of President Clinton’s first term to the end of other Congressional leaders have stepped forward to re- President George W. Bush’s second term, the National In- place these individuals as the unyielding defenders of bio- stitutes of Health (NIH) budget more than http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

The Future of Biomedical Research

JAMA , Volume 309 (15) – Apr 17, 2013

Loading next page...
 
/lp/american-medical-association/the-future-of-biomedical-research-GJYTV8IP0a
Publisher
American Medical Association
Copyright
Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2013.2096
pmid
23559019
Publisher site
See Article on Publisher Site

Abstract

VIEWPOINT ONLINE FIRST Second, for decades there have been strong Congressio- Ezekiel J. Emanuel, MD, PhD nal champions of the NIH. But such champions are quickly becoming an endangered species in Washington. John Por- HE COMMUNITY OF BIOMEDICAL RESEARCHERS IS ANX- ter, the former Illinois Republican Congressman who helped ious, if not downright depressed, about the future, guide the legislation that doubled the NIH budget, retired and there is good reason for this pessimism. For de- from politics in 2001; Senator Arlen Specter, who almost Tcades the importance of biomedical research was a single-handedly insisted on including a one-time $10 bil- reliable pillar of bipartisan agreement, as evidenced by the lion appropriation for the NIH in the American Recovery continuous high levels of funding that both parties have sus- and Reinvestment Act, recently died, as did the indefati- tained during the last 3 presidential administrations. From gable defender of NIH funding, Senator Ted Kennedy. No the beginning of President Clinton’s first term to the end of other Congressional leaders have stepped forward to re- President George W. Bush’s second term, the National In- place these individuals as the unyielding defenders of bio- stitutes of Health (NIH) budget more than

Journal

JAMAAmerican Medical Association

Published: Apr 17, 2013

References